Drug Profile
Research programme: anti-inflammatories - Pfizer
Alternative Names: AN 6415Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Anacor Pharmaceuticals
- Developer Anacor Pharmaceuticals; Pfizer
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Inflammation in USA (Topical)
- 03 Aug 2016 Discontinued - Preclinical for Inflammation in USA (PO)
- 03 Aug 2016 Early research in Inflammation in USA (Topical) before August 2016